Non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in living-donor liver transplantation (LDLTX)

被引：0
|
作者：
Yamamoto, K [1 ]
Takada, Y [1 ]
Fujimoto, Y [1 ]
Haga, H [1 ]
Egawa, H [1 ]
Tanaka, K [1 ]
机构：
[1] Kyoto Univ, Dept Transplanta & Immunol, Kyoto, Japan
来源：
LIVER TRANSPLANTATION | 2004年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
116
引用
收藏
页码：C29 / C29
页数：1
相关论文
共 50 条
  • [41] Predictive Factors for Nonalcoholic Steatohepatitis (NASH) in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
    Fierbinteanu-Braticevici, Carmen
    Baicus, Cristian
    Tribus, Laura
    Papacocea, Raluca
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2011, 20 (02) : 153 - 159
  • [42] Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) in Patients with Morbid Obesity
    Manno, Emilio
    OBESITY SURGERY, 2010, 20 (06) : 811 - 811
  • [43] Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD)
    Gerhardt, Florian
    Petroff, David
    Blank, Valentin
    Boehlig, Albrecht
    van Boemmel, Florian
    Wittekind, Christian
    Berg, Thomas
    Karlas, Thomas
    Wiegand, Johannes
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (06) : 706 - 711
  • [44] Clinical Predictors of Recurrent Non-Alcoholic Steatohepatitis Following Liver Transplantation for Non-Alcoholic Fatty Liver Disease
    Stein, L.
    Dunn, W.
    Nguyen, H.
    Bhasin, D.
    Pollinger, H.
    Johnson, M.
    Shrestha, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 703 - 703
  • [45] Living donor liver transplantation for non-alcoholic steatohepatitis: A single center experience
    Tanaka, Tomohiro
    Sugawara, Yasuhiko
    Tamura, Sumihito
    Kaneko, Junichi
    Takazawa, Yutaka
    Aoki, Taku
    Hasegawa, Kiyoshi
    Sakamoto, Yoshihiro
    Yamashiki, Noriyo
    Kokudo, Norihiro
    HEPATOLOGY RESEARCH, 2014, 44 (10) : E3 - E10
  • [46] Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Bifari, Francesco
    Manfrini, Roberto
    Cas, Michele Dei
    Berra, Cesare
    Siano, Matteo
    Zuin, Massimo
    Paroni, Rita
    Folli, Franco
    PHARMACOLOGICAL RESEARCH, 2018, 137 : 219 - 229
  • [47] Impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) on the expression and function of hepatobiliary transporters: A comprehensive mechanistic review
    Laddha, Ankit P.
    Dzielak, Lindsey
    Lewis, Cedric
    Xue, Raymond
    Manautou, Jose E.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (03):
  • [48] Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in High-Risk Undiagnosed Adults in South Florida
    Chaudhary, Dhishna
    Sidhu, Simran
    Manam, Rupesh
    Manraj, Kevan
    Lanza, Melaine
    DeDonno, Michael A.
    Baum, Seth J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S495 - S495
  • [49] Serum adiponectin levels correlate strongly with non-alcoholic steatohepatitis (NASH) grade and fibrosis stage in non-alcoholic fatty liver disease (NAFLD)
    Savvidou, Savvoula
    Goulis, John
    Hytiroglou, Prodromos
    Orfanou-Koumerkeridou, Eleni
    Frantzoulis, Peggy
    Panderis, Athanasia
    Arvanitakis, Constantine
    HEPATOLOGY, 2006, 44 (04) : 644A - 644A
  • [50] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
12345